Abstract:Purpose: Aberrant hedgehog (Hh) signaling has been reported in various cancers including breast cancers and clinical trials targeting this pathway are currently ongoing. Preclinical evidence suggests that increased ligand-dependent Hh signaling in breast tumor epithelial (E) cells cross-talks and activates Hh pathway in the stroma (S) but the clinical implication of this E/S interaction is unknown. We sought to determine the expression of Hh proteins in the E and S compartments of primary breast tumor samples and correlate with clinical outcomes. Methods: Using tissue microarray (TMA) of ∼500 primary breast cancer samples (OSU 2009C009 A) that includes both primary breast tumor and axillary metastasis, the expression pattern of the key Hh signaling proteins (Shh, Gli-1, SMO, Ptch1) and a target gene of the pathway (BMI1) was determined by immunohistochemistry (IHC) in both the epithelial and stromal tissues and compared to other known prognostic/predictive markers such as age, stage, estrogen/progesterone receptor (ER/PR)/HER2 status and to disease-free survival (DFS). IHC was performed using Benchmark LT automated system from Ventana Medical Systems using previously published methods (Nuovo GJ, Nature protocols, 2009). Scoring was done by combining the intensity and percentage of cells staining with respective antibodies by three independent measurements. Results: Analysis of a total of 315 primary breast tumors revealed the following percentage of tumors with high expression of Hh proteins in the E/S compartments respectively: Shh (72/31%), Gli-1 (69/53%), SMO (40/64%), and Ptch-1 (93/74%). Analyzing the interaction between the epithelial and stromal expressions of these proteins, we found positive correlation between i) high Shh and SMO in the epithelial cells and Gli-1 in the stroma, and ii) high Gli-1 in the epithelial cells and target protein Bmi1 in the stroma. High intensity staining of Gli-1 in the tumor epithelial cells was significantly associated with higher stage, grade, ER negative status and worse DFS. Adjusting for stage and ER status, tumors with increased epithelial Gli-1 expression was still significantly associated with worse DFS (p=0.0131, survival analysis) when compared to tumors with low expression. In particular, among the ER negative and node positive patients higher Gli-1 expression in epithelial cells was very significantly associated with poor DFS (p= Conclusions: We report here for the first time a positive correlation between expression of Hh proteins in the stromal and epithelial compartment of primary breast tumors. Furthermore, we observed that higher Gli-1 expression in the tumor epithelial cells was associated with worse DFS, particularly in the ER negative, node-positive tumors suggesting that aberrant Hh signaling may contribute to drug-resistance and hence a rationale therapeutic target. Further correlative studies between clinical parameters and additional Hh target genes in these tumors are in progress. Citation Information: Cancer Res 2010;70(24 Suppl):Abstract nr S6-9.

Expression of histone methyltransferase WHSC1 in invasive breast cancer and its correlation with clinical and pathological data

WHSC1 is involved in DNA damage, cellular senescence and immune response in hepatocellular carcinoma progression

The clinicopathological significance of HES1 promoter hypomethylation in patients with colorectal cancer.

Histone Methyltransferase WHSC1 Inhibits Colorectal Cancer Cell Apoptosis Via Targeting Anti-Apoptotic BCL2

WHSC1 Promotes Cell Proliferation, Migration, and Invasion in Hepatocellular Carcinoma by Activating mTORC1 Signaling

High Wilms' Tumor 1 Mrna Expression Correlates with Basal-Like and Erbb2 Molecular Subtypes and Poor Prognosis of Breast Cancer

WHSC1 Promotes Oncogenesis Through Regulation of NIMA-related Kinase-7 in Squamous Cell Carcinoma of the Head and Neck.

Expression and analysis of HIC-1 and HMMR in breast cancer

Presence of CHD1L Over-Expression Is Associated with Aggressive Tumor Biology and Is a Novel Prognostic Biomarker for Patient Survival in Human Breast Cancer

Expression Of Hedgehog Proteins In The Epithelial And Stromal Compartments Of Primary Breast Tumors And Its Prognostic Significance

CircWHSC1 serves as a prognostic biomarker and promotes malignant progression of non‐small‐cell lung cancer via miR‐590‐5p/SOX5 axis

Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers

Prognostic biomarker SMARCC1 and its association with immune infiltrates in hepatocellular carcinoma

Correlation of WIF-1 Expression and Clinicopathologic Significance in Breast Cancer with Aberrant DNA Methylation

Bioinformatics and Experimental Analysis of the Prognostic and Predictive Value of the CHPF Gene on Breast Cancer

HMGA1 As a Potential Prognostic and Therapeutic Biomarker in Breast Cancer

Expression and Potential Prognostic Value of Histone Family Gene Signature in Breast Cancer.

Expression and Regulation Mechanisms of Sonic Hedgehog in Breast Cancer

Expression of Hypoxia Inducing Factor 1 Alpha and Its Relationships with Proliferating Cell Nuclear Antigen and Microvessel Density in Human Breast Cancer

Expression of ZEB1 and Its Relationship with Prognosis in Breast Cancer

An immune biomarker associated with EMT serves as a predictor for prognosis and drug response in bladder cancer